EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Carbios (ALCRB) fair value: what the stock is really worth

As of Sep 24, 2026: fair value of Carbios €1.13, price €5.11, upside -77.9%, quality 26 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? No
  3. Add to watchlist

Basic Materials · FR · ISIN FR0011648716

C Thin data Sep 23, 2026

Carbios

ALCRB · PA

Weakest SetupStrongly overvalued and low quality.

!Fair value €1.13 · Strongly overvalued (−78%)
!Quality 26/100
!Mixed Growth (revenue 5y +89.2 %/yr)
!Low debt · negative free cash flow
!Trails peers (3/10)
!Narrow moat 12/100
!Evidence only low, so the estimate is less certain

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

€41.69 €4.99 Fair Value €1.13 Aug 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 23, 2026.

How to read this chart

60‑month range €4.99 – €41.69 · fair‑value band €0.7500 – €1.42 · the €5.11 price screens above the €1.13 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 23, 2026.

Follow Carbios in your weekly email

Every Wednesday you see whether Carbios is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Carbios SAS, engages in design and development of enzymatic processes in France. The company is also involved in enzymatic recycling and biodegradation activities. It exports its products. Carbios SAS was incorporated in 2011 and is headquartered in Clermont-Ferrand, France.

Stock analysis

Carbios (ALCRB) currently trades at €5.11, while our model-based Fair Value estimate is €1.13, implying the stock looks roughly 352.3% overvalued today.

Show more

Valuation

How firm this estimate is: it rests on 1 models at a data quality of 94/100, which puts the evidence level at low.

Scenario range: €0.7500 (bear) to €1.42 (bull), the price of €5.11 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 26/100 (below-average quality), in the Basic Materials sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Carbios reported revenue of €3.1M in FY2025 versus €105K in FY2021, a compound +133.1%/yr. Reported net income was −€34.3M in FY2025.

Key figures

Market cap €101M · P/E ratio 2.5 · P/S ratio 21.1 · EPS (TTM) €2.03 · Return on equity −16.3% · Return on assets (EBIT) −9.5% · Operating margin −1.9% · Revenue (TTM) €4.8M.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 38 out of 100 (low confidence).

What moves the price

The share trades about 66% below its 52-week high and at its 52-week low, currently below its 200-day average.

For context, the median of 10 Basic Materials peers we cover trades at −40% fair-value upside, at −78%, ALCRB screens richer than that median.

Fair Value models

Bear €0.7500 Fair Value €1.13 Bull €1.42
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (€1.49 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
NCAV (Graham) €5.74 €7.69 €11.48 54
All 1 models by family
Asset-Based
NCAV (Graham) €5.74 €7.69 €11.48 54

Open the full fair value analysis →

Notify me when ALCRB reaches fair value

Put ALCRB on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 26/100

Of which business quality 29 · Market factors (momentum, volatility) 10

Profitability 0
Margins and returns on capital today
Quality Growth 56
Are margins and returns improving?
Cashflow 0
Earnings quality: real cash, not paper profit
Fin. Strength 63
Balance sheet, leverage, solvency risk
Investment 27
Disciplined investing over empire-building
Low Volatility 11
Calm price path (market factor)
Momentum 16
Price trend over the last 3–12 months (market factor)
52W Momentum 0
Distance to the 52-week high (market factor)
Net Issuance 39
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 30/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+2,179.4%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+253.8%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+89.2%
Start year 2020 (pandemic). Over 10 years: +14.0% a year
Revenue growth 13 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+14.2%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−6,339.1% (2020) → −836.6% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

ALCRB screens 352% overvalued. Compare with Linde plc →

Compare Carbios with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 713 stocks

Beats the industry median on 3/9 measures
Overall it trails its industry peers.
Valuation
Quality Score 29 · Bottom 25%
Fair Value upside −78% · Bottom 25%
Profitability
Return on assets −6% · Bottom 25%
Operating margin (TTM) −2% · Bottom 25%
Growth and dividend
Revenue growth 87% · Top 25%
Balance sheet
Debt / equity 0.13× · Above median

Valuation Multiplesvs Specialty Chemicals median · lower = cheaper

P/E (TTM) 2.5× · Cheapest 25%
P/B 0.59× · Cheapest 25%
P/S (TTM) 24.05× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 0
FUTURE (revenue growth)100 · sector 21
PAST (return on equity)0 · sector 23
HEALTH (low debt)94 · sector 95
DIVIDEND (yield)0 · sector 29

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Linde plc LIN $469.72 $441.28 −6%
The Sherwin-Williams Company SHW $326.46 $148.97 −54%
Ecolab Inc ECL $276.72 $96.18 −65%
Air Products and Chemicals, Inc APD $286.97 $122.14 −57%
Nan Ya Plastics Corporation 1303 238.00 TWD 235.25 TWD −1%
Givaudan SA GIVN CHF 3,406 CHF 1,523 −55%
Wanhua Chemical Group 600309 ¥71.60 ¥68.03 −5%
Asian Paints Limited ASIANPAINT ₹2,455 ₹1,479 −40%
PPG Industries, Inc PPG $107.20 $77.06 −28%
DSM-Firmenich AG DSFIR CHF 91.50 CHF 29.27 −68%

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Carbios Fair Value". https://www.fairvalue-calculator.com/stock/ALCRB

Frequently asked questions

Is Carbios (ALCRB) overvalued or undervalued?
As of Sep 23, 2026, our model estimates a fair value of €1.13 versus a price of €5.11, about −78% upside (overvalued).
What is the fair value of ALCRB?
Our model-based fair value for Carbios is €1.13 (as of Sep 23, 2026), built from audited fundamentals. The current price: €5.11.
What is the quality score of ALCRB?
Carbios has a Quality Score of 26/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Carbios (ALCRB)?
Our model-based price target is the fair value of €1.13 (as of Sep 23, 2026) from 1 valuation models. Cautious scenario €0.7500, optimistic scenario €1.42. It is a calculation from audited fundamentals, not an analyst target.
What is the Carbios stock forecast for 2026?
Our models put fair value at €1.13, about −78% upside versus a price of €5.11 (overvalued). Cautious scenario €0.7500, optimistic scenario €1.42. The calculation is refreshed regularly with new filings.
What is the revenue of Carbios (ALCRB)?
Carbios reported trailing-twelve-month revenue of about €4.8M (latest available figure, as of Sep 23, 2026).
What is the intrinsic value of Carbios (ALCRB)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Carbios it is €1.13 per share (as of Sep 23, 2026), against a price of €5.11. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is Carbios stock overvalued or undervalued in 2026?
As of Sep 23, 2026, ALCRB trades above its calculated fair value: price €5.11, fair value €1.13, a gap of about −78% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of ALCRB?
No. The price is what the market pays today (€5.11); the fair value is what the company's own numbers justify (€1.13). For Carbios the two are €3.98 per share apart. That gap is exactly why we show both numbers side by side.
How much is Carbios worth?
The market values Carbios at about €101M (market capitalisation, as of Sep 23, 2026). Per share that is €5.11; our models calculate a fair value of €1.13 per share.
What do the bullish and bearish scenarios say about ALCRB?
Our models span a range for Carbios: cautious scenario €0.7500, base €1.13, optimistic €1.42 per share (as of Sep 23, 2026, price €5.11). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of ALCRB?
Carbios trades at a price-to-earnings ratio of 2.5 (as of Sep 23, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of €1.13 is built from several models across several years. Other multiples: P/B 0.6, P/S 24.0.
How solid is the balance sheet of Carbios (ALCRB)?
Balance-sheet figures for Carbios (as of Sep 23, 2026): return on equity −16.3%, debt of 0.13 per unit of equity. They feed the Quality Score of 26/100, which measures business quality independently of the share price.
How far is ALCRB from its 52-week high?
Carbios trades at €5.11, about 66% below its 52-week high of €15.14 and at the low of €5.11 (as of Sep 24, 2026). Distance from the high says nothing about value: that is what the fair value of €1.13 is for.
Which stocks are comparable to Carbios?
From the same area (Basic Materials) we also value Linde plc, The Sherwin-Williams Company, Ecolab Inc, Air Products and Chemicals, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Carbios stock attractive at the current price?
The data as of Sep 23, 2026: price €5.11, calculated fair value €1.13 (−78%), Quality Score 26/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of ALCRB calculated?
We run Carbios through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of €1.13, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0 % above its aggregate fair value. Carbios itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Carbios (ALCRB)?
The closing price on Sep 24, 2026 was €5.11. Our model-based fair value is €1.13, about −78% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Carbios right now?
The price sits above even our optimistic bull case (€1.42). The favourable scenario is already priced in. Weak quality (26/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range (€0.7500 to €1.42) leaves room in how you read the outcome.

Key figures of Carbios

How large is the market capitalisation of Carbios (ALCRB)?
The market capitalisation of Carbios is €101M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Carbios (ALCRB)?
The price-to-sales ratio of Carbios is 21.1 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Carbios (ALCRB)?
Earnings per share at Carbios are €2.03 (price ÷ EPS = P/E 2.5). Earnings per share over the last twelve months: total profit spread across every single share.
What is the return on equity of Carbios (ALCRB)?
The return on equity (ROE) of Carbios is −16.3% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Carbios (ALCRB)?
On an EBIT basis the return on assets of Carbios is −9.5% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Carbios (ALCRB)?
The operating margin of Carbios is −1.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Carbios (ALCRB)?
Revenue at Carbios is growing +87.4% versus a year earlier (3y avg +254%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Carbios (ALCRB) generate?
The free cash flow of Carbios is −€18.4M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Carbios (ALCRB) hold?
Carbios holds more cash than debt, €9.3M net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Carbios in the live analysis

One click puts Carbios on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.